✦ LIBER ✦

PCN78 THE DEVELOPMENT OF A VALUE BASED PRICING INDEX FOR NEW DRUGS IN METASTATIC COLORECTAL CANCER

✍ Scribed by G. Dranitsaris; I. Truter; M. Lubbe

Book ID: 119309689
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 59 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.933

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of a value based pricing

The development of a value based pricing index for new drugs in metastatic colorectal cancer

✍ George Dranitsaris; Ilse Truter; Martie S. Lubbe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 157 KB

PCN70 USING PHARMACOECONOMIC MODELING TO

PCN70 USING PHARMACOECONOMIC MODELING TO DETERMINE A VALUE-BASED PRICE OF NEW CANCER DRUGS IN MALAYSIA

✍ G. Dranitsaris; I. Truter; M. Lubbe; S. Mahagaonkar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

The application of pharmacoeconomic mode

The application of pharmacoeconomic modelling to estimate a value-based price for new cancer drugs

✍ George Dranitsaris; Ilse Truter; Martie S. Lubbe; Wayne Cottrell; Biljana Spirov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

A population-based study of metastatic c

A population-based study of metastatic colorectal cancer in individuals aged ≥80 years : Findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer

✍ Rajiv Kumar; Kunal Jain; Carol Beeke; Timothy J. Price; Amanda R. Townsend; Rob 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

PR1 THE APPLICATION OF PHARMACOECONOMIC

PR1 THE APPLICATION OF PHARMACOECONOMIC MODELING TO ESTIMATE A VALUE-BASED PRICE FOR NEW CANCER DRUGS IN A PUBLICLY FUNDED HEALTH-CARE SYSTEM

✍ G Dranitsaris; I Truter; M Lubbe; B Spirovski; W Cottrell; J Edwards 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Prognostic index for the development of

Prognostic index for the development of liver metastases in patients with colorectal cancer

✍ Professor I. Taylor; M. A. Mullee; M. J. Campbell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views

## Abstract The incidence of synchronous and metachronous liver metastases in patients with colorectal cancer is extremely high. Approximately 25 per cent of patients will have overt liver metastases at the time of presentation, and in the remainder up to 40 per cent will eventually develop liver m